.With theadventofrigidendoscopesand endoscopic instrumentation,endonasalDCRhasbecomeanalternative methodtoexternalDCR,butthesuccessrateofthis procedurewasfoundtobelowerthantheconventional method [2] [3] .Themostfrequentlyreportedcausesoffailurein DCRareobstructionofthecommoncanalicullusandclosure oftheosteotomysiteduetoboneregrowth,fibrosis,scarring, andgranulationtissue [4] .Theideaofinhibitingthecausesof failuremadetheintraoperativeapplicationofthe antiproliferativeagentstobeconsideredasanadjunctive therapyinDCR.Mitomycin-C(MMC)hasbeenthemost popularantifibroticagentusedinDCRaswellasin pterygiumexcisionandglaucomasurgerywithfavourable results [5] [6] [7] [8] .Ontheotherhand,thepresenceofwell documentedocularcomplicationsrelatedtotheadjunctive useofMMCinpterygiumandfiltrationsurgery [9] [10] andthe currentcontroversiesregardingtheoptimaldosageand exposuretimeofMMC [5, 7, 11] bringconsiderablelimitations abouttheroutineuseofthisdruginophthalmicsurgery. Normalwoundhealingprocessmayalsointerferewiththe patencyofintranasalostiumafterthesurgery [8] .Fibrinis accusedasakeyproductinthisprocessthatresultsin granulationandscartissueformationandeventuallybone regrowth [12] .Thereforedecreasingorinhibitingfibrin productionbypharmacologicalinterruptionofthe coagulationcascadeseemstobealogicalandanalternative [13] .Althoughithasbeengenerally acceptedthatanosteotomysizeof15to20mmindiameter isenoughtobesuccessfulinexternalDCR,Linberg [14] showedthatthediameterofthehealedintranasalostiumwas decreasedto1.8mm,thatwasonly10%sizeoftheinitial surgicalostium,inthepostoperativeperiodwithexcellent functionalresults [15] .ThisfindingmadeendoscopicDCRas analternativemethodwithlessdisfavorsascomparedto externalDCR.However,thesuccessrateofendoscopicDCR wasfoundtobelowerthanexternalDCR [2] .Obstructionof thecommoncanalicullusandclosureoftherhinostomysite duetotheconsequencesofnormalwoundhealingpathways, suchasboneregrowth,fibrosis,scarring,andgranulation tissuehavebeenreportedasthemostcommoncausesof DCRfailure [3] [4] 13] . [16] ,normalwoundhealing cascadecantheoreticallybemodulatedatseveralstagesby usingdifferent pharmacologicalagentsinterferingwith particularfactorsinvolvedinthepathway.Theysimply classifiedtheseagentsintofourgroupswithregardtothe mainphasesofrepair:coagulative,inflammatory, proliferative,andpost-proliferative remodeling.Many authors,forexample,recommendtheintraoperative applicationofMMCtothesurgicalanastamosisasan antiproliferativeagentinthismanner [7] [8] .MMCisan alkylatingagentthatinhibitsfibroblastproliferationatthe rhinostomysitewithfavourableoutcomes.However,itsuse [9] .Therefore,therehavebeensomeeffortsto findasubstituteforMMCinpreventionofsurgicalfailure. Pharmacologicallyinterruptingthecoagulationcascadeatan earlierstepcouldtheoreticallymodulatethewoundhealing responseandpreventtheclosureofsurgicalosteotomy. Zilelioglu [8] reportedthatthedecreaseinthesizeofthe healedintranasalostiumaftersurgerywastheresultofa normalwoundhealingresponse.Woundhealingmaybe consideredasoneoftheactivitiesofhemostasis,whichis initiatedbydirecttissueinjuryandbloodvesseldisruptionas aresultofsurgicalmanipulation.Fibrinistheendproductof thecoagulationprocessandisformedbyconversionof fibrinogentofibrinbythrombin.Fibrinisresponsiblefora seriesofhistochemicalreactions,suchasplatelet aggregation,proliferationandsynthesis ofextracellular matrix,thateventuallyresultingranulationandscartissue formation [12] . Bothheparinanditsderivative,LMWH,cansuccessfully inhibitthrombusformation.Heparinhassomelimitations basedonitspharmacokinetic,biophysical,andbiological propertiesnotsharedbyLMWHs [17] .LMWHpreparationsare producedbychemicalorenzymaticdepolymerizationof nativeheparinandareconsideredtobemoreconvenientin theprophylacticinhibitionoffibrinformation.Thestudies concerningtheefficacyandsafetyofLMWHshaveshown thatLMWHsequallypreventdeepvenousthrombosisand pulmonaryembolismandresultinsignificantlylesser bleedingcomplicationswhencomparedtounfractionated heparinandwarfarin [18] .LMWHsdonotineractwithplatelet functionanddonotmodifybleedingtime,thus,requiringless intenselaboratorymonitoring.AlthoughLMWHsaremainly usedforthromboprophylaxisinorthopedicsurgery,theyhave beenalsofoundtobesafeandeffectiveinthepreventionof ocularscarringandneovascularizationdisordersbyreduction ofcell-mediatedcontractionandcellularproliferation [18] [19] . Thesubjectofthecurrentstudyismainlybasedonthe clinicalandexperimentalobservationselucidatingtheside effectsofLMWHsonbonehealingprocess.Long-termuses ofheparinandLMWHshavebeenshowntocarryariskof osteoporosisasabiologicallimitation [20] [21] [22] .Standardheparin hasbeenreportedtodecreaseboneformationandincrease boneresorption [22] .Although,thereareanumberofstudies reportingasimilaroralessereffectofLMWHsonthe skeletalsystem,theexactmechanismofLMWHsonbone healingwhenusedwithastandarddosagefor thromboprophylaxishavenotbeenfullyunderstood [20] [21] [22] [23] .Inan unstabilizedrabbitribfracturemodel,Street [24] has suggestedthatashort-termadministrationof LMWH thromboprophylaxiswoulddelaybonehealingbytwodistinct mechanisms,eitherbydisruptingtheformationof 
